Search results for: 'cross 27s diseases partnering 2004 2004'
- Did you mean
- cost 27s diseases partnering 2016 2016
- Related search terms
- partnering agreements with astrazeneca 2025 2020
- partnering agreements with dainippon sumitomo 2025 2025
- partnering agreements with galapagos 2025 2020
- partnering agreements while biogen infect 2025 2025
- partnering agreements while need therapeutic 2016 2016
-
Infectious Disease Collaboration and Licensing Deals 2019-2026April 2026$4,995.00Infectious Disease Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2026
Learn More -
Global Biotech Partnering Terms and Agreements 2018-2023March 2023$3,995.00Global Biotech Partnering Terms and Agreements 2018 to 2023 report provides a detailed understanding and analysis of how and why companies enter biotech partnering deals.
Learn More -
Molecular Diagnostics for Infectious Disease: Market Forecasts by Syndrome, Plex, Place and Country with Analysis and Executive Guides 2025-2029January 2025$6,995.00Infectious Disease Molecular Diagnostics (MDx) Markets | Global coverage | Market size | Actionable insights| Trends | Key companies | Growth forecasts
Learn More -
Academic and Non-Profit Partnering Terms and Agreements 2021-2026March 2026$4,995.00Academic and Non-Profit Partnering Terms and Agreements 2021-2026 provides a detailed understanding and analysis of how and why companies enter Academic and Non-Profit partnering deals.
Learn More -
Specialty Pharmaceutical Partnering Terms and Agreements 2020-2026March 2026$3,995.00Specialty Pharmaceutical Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter specialty pharmaceutical partnering deals.
Learn More -
Current Partnering Knowledge CenterApril 2026$14,995.00The Leading Partnering Intelligence Platform for Pharma, Biotech and Diagnostic Dealmakers
Learn More -
Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech (2020-2026) report offers in-depth insights and exclusive access to preclinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More -
Big Pharma Partnering Terms and Agreements 2020-2025July 2025$5,995.00Provides a detailed understanding and analysis of how and why companies enter Big Pharma partnering deals
Learn More -
Generic Pharmaceutical Partnering Terms and Agreements 2010-2026January 2026$3,995.00Global Generic Pharmaceutical Partnering Terms and Agreements 2010 to 2026 report provides a detailed understanding and analysis of how and why companies enter generic pharmaceutical partnering deals.
Learn More -
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026March 2026$4,995.00The Clinical Stage Partnering Terms and Agreements in Pharma and Biotech report offers in-depth insights and exclusive access to clinical-stage partnering agreements signed by the world’s leading biopharma companies, providing a detailed analysis of deal structures, financial terms and strategic collaborations.
Learn More
